Dashboard
Manage Tickers

ATHE ALTERITY THERAPEUTICS LTD

Nasdaq alteritytherapeutics.com


$ 3.68 $ 0.00 (0 %)    

Tuesday, 11-Nov-2025 11:01:21 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 620.90 $ 0.29 (0.05 %)
DIA $ 478.19 $ 4.08 (0.86 %)
SPY $ 681.97 $ 1.99 (0.3 %)
TLT $ 89.94 $ 0.00 (0.01 %)
GLD $ 378.52 $ -1.49 (-0.39 %)
$ 3.746
$ 3.79
$ 3.66 x 100
$ 3.75 x 20
-- - --
$ 1.00 - $ 7.00
19,853
na
327.47M
$ 0.92
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

alterity-therapeutics-presents-data-on-orthostatic-hypotension-from-its-ath434-201-phase-2-clinical-study-in-multiple-system-atrophy
Alterity Therapeutics Presents Data On Ort...
11/10/2025 12:27:14

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated...

alterity-therapeutics-reports-stronger-ath434-phase-2-efficacy-signal-positive-advanced-msa-data-sees-usd-24-billion-peak-sales-potential
Alterity Therapeutics Reports Stronger ATH...
10/31/2025 11:29:42

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
10/14/2025 12:09:03

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/09/2025 21:06:16

alterity-therapeutics-presents-data-from-ath434-201-randomized-double-blind-phase-2-clinical-trial-in-msa-at-2025-international-congress-of-parkinsons-disease-and-mds
Alterity Therapeutics Presents Data From A...
10/09/2025 11:27:38

– Data demonstrate ATH434 slows disease progression and stabilizes orthostatic hypotension –– New analysis increases overall co...

alterity-to-present-multiple-system-atrophy-drug-trial-results-at-major-parkinsons-conference-in-hawaii
Alterity to Present Multiple System Atroph...
10/02/2025 11:37:01

Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated...

alterity-therapeutics-phase-2-trial-shows-ath434-slowed-progression-of-rare-brain-disorder-msa
Alterity Therapeutics Phase 2 Trial Shows ...
09/15/2025 11:26:06

Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated...

alterity-therapeutics-raises-20m-to-advance-fda-path-for-promising-neurodegenerative-drug
Alterity Therapeutics Raises $20M to Advan...
09/08/2025 11:36:39

Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated...

trading-halt-halt-status-updated-at-70000-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:00:...
09/08/2025 11:00:08

trading-halt-halted-at-72636-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:26:36 p.m. ET - ...
09/03/2025 23:26:41

alterity-therapeutics-faces-asx-inquiry-over-a-10day-delay-in-announcing-july-14-mri-study-publication
Alterity Therapeutics Faces ASX Inquiry Ov...
08/06/2025 11:28:19

alterity-therapeutics-faces-asx-inquiry-over-10day-delay-in-announcing-july-14-mri-study-publication
Alterity Therapeutics Faces ASX Inquiry Ov...
08/06/2025 11:25:26

alterity-faces-asx-scrutiny-over-timing-of-market-sensitive-mri-study-announcement
Alterity Faces ASX Scrutiny Over Timing of...
08/04/2025 11:59:25

Alterity Therapeutics Limited (‘ATH'): ASX Aware LetterASX refers to the following:A.ATH's announcement titled ‘Alterit...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
07/28/2025 17:06:06

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
07/28/2025 12:08:27

alterity-therapeutics-announces-topline-data-from-ath434-202-open-label-phase-2-clinical-trial-in-individuals-with-multiple-system-atrophy
Alterity Therapeutics Announces Topline Da...
07/28/2025 11:27:07

– ATH434 Demonstrated Clinical Benefit on the Unified MSA Rating Scale and Global Measures of Neurological Symptoms –– Neuroima...

alterity-therapeutics-says-peer-reviewed-publication-in-annals-of-clinical-and-translational-neurology-highlights-use-of-msa-atrophy-index-developed-to-diagnose-and-track-disease-progression-in-multiple-system-atrophy
Alterity Therapeutics Says Peer-Reviewed P...
07/24/2025 11:28:40

Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
07/18/2025 12:07:40

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
07/11/2025 17:06:03

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
07/11/2025 12:07:13

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION